The impact of preceding infections on the clinical presentation and prognosis of Guillain-Barré Syndrome: A focus on post-COVID-19 GBS Article Swipe
Jaisingh Rajput
,
Pradyuman Singh Rajput
,
Elan Mohanty
,
Gurpreet Kaur Saini
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1016/j.dscb.2025.100196
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1016/j.dscb.2025.100196
This paper aims at comparing the results of GBS patients with SARS-CoV-2 infection with those patients who have developed the condition due to other infections including Campylobacter and Zika virus. In all, 295 confirmed GBS cases following COVID-19 vaccination were evaluated and showed 93.2 % of higher hospitalisation and substantial respiratory involvement, suggesting that COVID-19 vaccinated GBS course is more severe than GBS with other infections. Although the GBS development in Campylobacter-associated cases is considered to reveal less severe symptoms and more favourable prognosis after IVIG or plasmapheresis application, only 62 percent of COVID-19-associated GBS patients demonstrated the improvement, and long-term comorbidity is more expressive. The study also emphasizes that early symptoms and its severity are the key components for establishing the prognosis of the disease; patients with higher initial symptom severity initially often experience longer stays in the hospital and statistically worse outcomes. Moreover, different immunity to pathogens, revealed by MAbs, are underlain by dissimilar prognosis depending on the cause of infection. Thus, these results emphasise the need for a highly tailored approach to clinical management of GBS patients that would involve attention to the infectious pathogen. More study is required to fine-tune medical approach and enhance people's well-being since pathogens change over the time. The findings of this scholarly work add to the current understanding of the diverse manifestations and characteristics of GBS and inform clinical practice regarding the post-infectious neurological sequelae of the disease more broadly.
Related Topics
Concepts
Guillain-Barre syndrome
Coronavirus disease 2019 (COVID-19)
Presentation (obstetrics)
Medicine
Focus (optics)
2019-20 coronavirus outbreak
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Virology
Intensive care medicine
Pediatrics
Internal medicine
Disease
Outbreak
Infectious disease (medical specialty)
Surgery
Physics
Optics
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1016/j.dscb.2025.100196
- OA Status
- gold
- References
- 14
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4407250361
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4407250361Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1016/j.dscb.2025.100196Digital Object Identifier
- Title
-
The impact of preceding infections on the clinical presentation and prognosis of Guillain-Barré Syndrome: A focus on post-COVID-19 GBSWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-02-08Full publication date if available
- Authors
-
Jaisingh Rajput, Pradyuman Singh Rajput, Elan Mohanty, Gurpreet Kaur SainiList of authors in order
- Landing page
-
https://doi.org/10.1016/j.dscb.2025.100196Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1016/j.dscb.2025.100196Direct OA link when available
- Concepts
-
Guillain-Barre syndrome, Coronavirus disease 2019 (COVID-19), Presentation (obstetrics), Medicine, Focus (optics), 2019-20 coronavirus outbreak, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Virology, Intensive care medicine, Pediatrics, Internal medicine, Disease, Outbreak, Infectious disease (medical specialty), Surgery, Physics, OpticsTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
14Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4407250361 |
|---|---|
| doi | https://doi.org/10.1016/j.dscb.2025.100196 |
| ids.doi | https://doi.org/10.1016/j.dscb.2025.100196 |
| ids.openalex | https://openalex.org/W4407250361 |
| fwci | 0.0 |
| type | article |
| title | The impact of preceding infections on the clinical presentation and prognosis of Guillain-Barré Syndrome: A focus on post-COVID-19 GBS |
| biblio.issue | |
| biblio.volume | 17 |
| biblio.last_page | 100196 |
| biblio.first_page | 100196 |
| topics[0].id | https://openalex.org/T11735 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2728 |
| topics[0].subfield.display_name | Neurology |
| topics[0].display_name | Peripheral Neuropathies and Disorders |
| topics[1].id | https://openalex.org/T11368 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9941999912261963 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2728 |
| topics[1].subfield.display_name | Neurology |
| topics[1].display_name | Long-Term Effects of COVID-19 |
| topics[2].id | https://openalex.org/T11282 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9567000269889832 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2738 |
| topics[2].subfield.display_name | Psychiatry and Mental health |
| topics[2].display_name | Fibromyalgia and Chronic Fatigue Syndrome Research |
| is_xpac | False |
| apc_list.value | 1700 |
| apc_list.currency | USD |
| apc_list.value_usd | 1700 |
| apc_paid.value | 1700 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 1700 |
| concepts[0].id | https://openalex.org/C2778691916 |
| concepts[0].level | 2 |
| concepts[0].score | 0.9665311574935913 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q205214 |
| concepts[0].display_name | Guillain-Barre syndrome |
| concepts[1].id | https://openalex.org/C3008058167 |
| concepts[1].level | 4 |
| concepts[1].score | 0.7429181337356567 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q84263196 |
| concepts[1].display_name | Coronavirus disease 2019 (COVID-19) |
| concepts[2].id | https://openalex.org/C2777601897 |
| concepts[2].level | 2 |
| concepts[2].score | 0.6066040396690369 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q3409113 |
| concepts[2].display_name | Presentation (obstetrics) |
| concepts[3].id | https://openalex.org/C71924100 |
| concepts[3].level | 0 |
| concepts[3].score | 0.5320770740509033 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[3].display_name | Medicine |
| concepts[4].id | https://openalex.org/C192209626 |
| concepts[4].level | 2 |
| concepts[4].score | 0.5289072394371033 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q190909 |
| concepts[4].display_name | Focus (optics) |
| concepts[5].id | https://openalex.org/C3006700255 |
| concepts[5].level | 3 |
| concepts[5].score | 0.4624035954475403 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q81068910 |
| concepts[5].display_name | 2019-20 coronavirus outbreak |
| concepts[6].id | https://openalex.org/C3007834351 |
| concepts[6].level | 5 |
| concepts[6].score | 0.4546627402305603 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q82069695 |
| concepts[6].display_name | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
| concepts[7].id | https://openalex.org/C159047783 |
| concepts[7].level | 1 |
| concepts[7].score | 0.43425440788269043 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q7215 |
| concepts[7].display_name | Virology |
| concepts[8].id | https://openalex.org/C177713679 |
| concepts[8].level | 1 |
| concepts[8].score | 0.38654160499572754 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q679690 |
| concepts[8].display_name | Intensive care medicine |
| concepts[9].id | https://openalex.org/C187212893 |
| concepts[9].level | 1 |
| concepts[9].score | 0.34647828340530396 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q123028 |
| concepts[9].display_name | Pediatrics |
| concepts[10].id | https://openalex.org/C126322002 |
| concepts[10].level | 1 |
| concepts[10].score | 0.12418228387832642 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[10].display_name | Internal medicine |
| concepts[11].id | https://openalex.org/C2779134260 |
| concepts[11].level | 2 |
| concepts[11].score | 0.0850861668586731 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[11].display_name | Disease |
| concepts[12].id | https://openalex.org/C116675565 |
| concepts[12].level | 2 |
| concepts[12].score | 0.06040939688682556 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q3241045 |
| concepts[12].display_name | Outbreak |
| concepts[13].id | https://openalex.org/C524204448 |
| concepts[13].level | 3 |
| concepts[13].score | 0.05431032180786133 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q788926 |
| concepts[13].display_name | Infectious disease (medical specialty) |
| concepts[14].id | https://openalex.org/C141071460 |
| concepts[14].level | 1 |
| concepts[14].score | 0.04689505696296692 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q40821 |
| concepts[14].display_name | Surgery |
| concepts[15].id | https://openalex.org/C121332964 |
| concepts[15].level | 0 |
| concepts[15].score | 0.04643237590789795 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q413 |
| concepts[15].display_name | Physics |
| concepts[16].id | https://openalex.org/C120665830 |
| concepts[16].level | 1 |
| concepts[16].score | 0.0 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q14620 |
| concepts[16].display_name | Optics |
| keywords[0].id | https://openalex.org/keywords/guillain-barre-syndrome |
| keywords[0].score | 0.9665311574935913 |
| keywords[0].display_name | Guillain-Barre syndrome |
| keywords[1].id | https://openalex.org/keywords/coronavirus-disease-2019 |
| keywords[1].score | 0.7429181337356567 |
| keywords[1].display_name | Coronavirus disease 2019 (COVID-19) |
| keywords[2].id | https://openalex.org/keywords/presentation |
| keywords[2].score | 0.6066040396690369 |
| keywords[2].display_name | Presentation (obstetrics) |
| keywords[3].id | https://openalex.org/keywords/medicine |
| keywords[3].score | 0.5320770740509033 |
| keywords[3].display_name | Medicine |
| keywords[4].id | https://openalex.org/keywords/focus |
| keywords[4].score | 0.5289072394371033 |
| keywords[4].display_name | Focus (optics) |
| keywords[5].id | https://openalex.org/keywords/2019-20-coronavirus-outbreak |
| keywords[5].score | 0.4624035954475403 |
| keywords[5].display_name | 2019-20 coronavirus outbreak |
| keywords[6].id | https://openalex.org/keywords/severe-acute-respiratory-syndrome-coronavirus-2 |
| keywords[6].score | 0.4546627402305603 |
| keywords[6].display_name | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
| keywords[7].id | https://openalex.org/keywords/virology |
| keywords[7].score | 0.43425440788269043 |
| keywords[7].display_name | Virology |
| keywords[8].id | https://openalex.org/keywords/intensive-care-medicine |
| keywords[8].score | 0.38654160499572754 |
| keywords[8].display_name | Intensive care medicine |
| keywords[9].id | https://openalex.org/keywords/pediatrics |
| keywords[9].score | 0.34647828340530396 |
| keywords[9].display_name | Pediatrics |
| keywords[10].id | https://openalex.org/keywords/internal-medicine |
| keywords[10].score | 0.12418228387832642 |
| keywords[10].display_name | Internal medicine |
| keywords[11].id | https://openalex.org/keywords/disease |
| keywords[11].score | 0.0850861668586731 |
| keywords[11].display_name | Disease |
| keywords[12].id | https://openalex.org/keywords/outbreak |
| keywords[12].score | 0.06040939688682556 |
| keywords[12].display_name | Outbreak |
| keywords[13].id | https://openalex.org/keywords/infectious-disease |
| keywords[13].score | 0.05431032180786133 |
| keywords[13].display_name | Infectious disease (medical specialty) |
| keywords[14].id | https://openalex.org/keywords/surgery |
| keywords[14].score | 0.04689505696296692 |
| keywords[14].display_name | Surgery |
| keywords[15].id | https://openalex.org/keywords/physics |
| keywords[15].score | 0.04643237590789795 |
| keywords[15].display_name | Physics |
| language | en |
| locations[0].id | doi:10.1016/j.dscb.2025.100196 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4210215057 |
| locations[0].source.issn | 2666-4593 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2666-4593 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Brain Disorders |
| locations[0].source.host_organization | https://openalex.org/P4310320990 |
| locations[0].source.host_organization_name | Elsevier BV |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320990 |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Brain Disorders |
| locations[0].landing_page_url | https://doi.org/10.1016/j.dscb.2025.100196 |
| locations[1].id | pmh:oai:doaj.org/article:a6be145296f441c986e3c979b1707e93 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306401280 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[1].source.host_organization | |
| locations[1].source.host_organization_name | |
| locations[1].source.host_organization_lineage | |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | article |
| locations[1].license_id | |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | Brain Disorders, Vol 17, Iss , Pp 100196- (2025) |
| locations[1].landing_page_url | https://doaj.org/article/a6be145296f441c986e3c979b1707e93 |
| indexed_in | crossref, doaj |
| authorships[0].author.id | https://openalex.org/A5111948968 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Jaisingh Rajput |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Jaisingh Rajput |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5089116204 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-6569-9751 |
| authorships[1].author.display_name | Pradyuman Singh Rajput |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Prajakta rajput |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5022933950 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Elan Mohanty |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Elan Mohanty |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5018168487 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Gurpreet Kaur Saini |
| authorships[3].author_position | last |
| authorships[3].raw_author_name | Gurpreet Kaur Saini |
| authorships[3].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1016/j.dscb.2025.100196 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | The impact of preceding infections on the clinical presentation and prognosis of Guillain-Barré Syndrome: A focus on post-COVID-19 GBS |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11735 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2728 |
| primary_topic.subfield.display_name | Neurology |
| primary_topic.display_name | Peripheral Neuropathies and Disorders |
| related_works | https://openalex.org/W3127156785, https://openalex.org/W3009669391, https://openalex.org/W4200329650, https://openalex.org/W4205215807, https://openalex.org/W3005417802, https://openalex.org/W4205754011, https://openalex.org/W4226296940, https://openalex.org/W3028835529, https://openalex.org/W3036314732, https://openalex.org/W3134376730 |
| cited_by_count | 0 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1016/j.dscb.2025.100196 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4210215057 |
| best_oa_location.source.issn | 2666-4593 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2666-4593 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Brain Disorders |
| best_oa_location.source.host_organization | https://openalex.org/P4310320990 |
| best_oa_location.source.host_organization_name | Elsevier BV |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| best_oa_location.license | |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Brain Disorders |
| best_oa_location.landing_page_url | https://doi.org/10.1016/j.dscb.2025.100196 |
| primary_location.id | doi:10.1016/j.dscb.2025.100196 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4210215057 |
| primary_location.source.issn | 2666-4593 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2666-4593 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Brain Disorders |
| primary_location.source.host_organization | https://openalex.org/P4310320990 |
| primary_location.source.host_organization_name | Elsevier BV |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Brain Disorders |
| primary_location.landing_page_url | https://doi.org/10.1016/j.dscb.2025.100196 |
| publication_date | 2025-02-08 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W4318755486, https://openalex.org/W2057501484, https://openalex.org/W2158728622, https://openalex.org/W4210489865, https://openalex.org/W4321362106, https://openalex.org/W4318914940, https://openalex.org/W4224274356, https://openalex.org/W4402365380, https://openalex.org/W3156553414, https://openalex.org/W3130869484, https://openalex.org/W2550719446, https://openalex.org/W2127884861, https://openalex.org/W4310992590, https://openalex.org/W4404221941 |
| referenced_works_count | 14 |
| abstract_inverted_index.% | 44 |
| abstract_inverted_index.a | 170 |
| abstract_inverted_index.62 | 90 |
| abstract_inverted_index.In | 30 |
| abstract_inverted_index.at | 3 |
| abstract_inverted_index.by | 150, 154 |
| abstract_inverted_index.in | 70, 137 |
| abstract_inverted_index.is | 58, 73, 102, 190 |
| abstract_inverted_index.of | 7, 45, 92, 123, 161, 177, 208, 217, 223, 234 |
| abstract_inverted_index.on | 158 |
| abstract_inverted_index.or | 86 |
| abstract_inverted_index.to | 22, 75, 147, 174, 184, 192, 213 |
| abstract_inverted_index.295 | 32 |
| abstract_inverted_index.GBS | 8, 34, 56, 62, 68, 94, 178, 224 |
| abstract_inverted_index.The | 105, 206 |
| abstract_inverted_index.add | 212 |
| abstract_inverted_index.and | 27, 41, 48, 80, 99, 112, 140, 196, 221, 225 |
| abstract_inverted_index.are | 115, 152 |
| abstract_inverted_index.due | 21 |
| abstract_inverted_index.for | 119, 169 |
| abstract_inverted_index.its | 113 |
| abstract_inverted_index.key | 117 |
| abstract_inverted_index.the | 5, 19, 67, 97, 116, 121, 124, 138, 159, 167, 185, 204, 214, 218, 230, 235 |
| abstract_inverted_index.who | 16 |
| abstract_inverted_index.93.2 | 43 |
| abstract_inverted_index.IVIG | 85 |
| abstract_inverted_index.More | 188 |
| abstract_inverted_index.This | 0 |
| abstract_inverted_index.Zika | 28 |
| abstract_inverted_index.aims | 2 |
| abstract_inverted_index.all, | 31 |
| abstract_inverted_index.also | 107 |
| abstract_inverted_index.have | 17 |
| abstract_inverted_index.less | 77 |
| abstract_inverted_index.more | 59, 81, 103, 237 |
| abstract_inverted_index.need | 168 |
| abstract_inverted_index.only | 89 |
| abstract_inverted_index.over | 203 |
| abstract_inverted_index.than | 61 |
| abstract_inverted_index.that | 53, 109, 180 |
| abstract_inverted_index.this | 209 |
| abstract_inverted_index.were | 39 |
| abstract_inverted_index.with | 10, 13, 63, 127 |
| abstract_inverted_index.work | 211 |
| abstract_inverted_index.MAbs, | 151 |
| abstract_inverted_index.Thus, | 163 |
| abstract_inverted_index.after | 84 |
| abstract_inverted_index.cases | 35, 72 |
| abstract_inverted_index.cause | 160 |
| abstract_inverted_index.early | 110 |
| abstract_inverted_index.often | 133 |
| abstract_inverted_index.other | 23, 64 |
| abstract_inverted_index.paper | 1 |
| abstract_inverted_index.since | 200 |
| abstract_inverted_index.stays | 136 |
| abstract_inverted_index.study | 106, 189 |
| abstract_inverted_index.these | 164 |
| abstract_inverted_index.those | 14 |
| abstract_inverted_index.time. | 205 |
| abstract_inverted_index.worse | 142 |
| abstract_inverted_index.would | 181 |
| abstract_inverted_index.change | 202 |
| abstract_inverted_index.course | 57 |
| abstract_inverted_index.higher | 46, 128 |
| abstract_inverted_index.highly | 171 |
| abstract_inverted_index.inform | 226 |
| abstract_inverted_index.longer | 135 |
| abstract_inverted_index.reveal | 76 |
| abstract_inverted_index.severe | 60, 78 |
| abstract_inverted_index.showed | 42 |
| abstract_inverted_index.virus. | 29 |
| abstract_inverted_index.current | 215 |
| abstract_inverted_index.disease | 236 |
| abstract_inverted_index.diverse | 219 |
| abstract_inverted_index.enhance | 197 |
| abstract_inverted_index.initial | 129 |
| abstract_inverted_index.involve | 182 |
| abstract_inverted_index.medical | 194 |
| abstract_inverted_index.percent | 91 |
| abstract_inverted_index.results | 6, 165 |
| abstract_inverted_index.symptom | 130 |
| abstract_inverted_index.Although | 66 |
| abstract_inverted_index.COVID-19 | 37, 54 |
| abstract_inverted_index.approach | 173, 195 |
| abstract_inverted_index.broadly. | 238 |
| abstract_inverted_index.clinical | 175, 227 |
| abstract_inverted_index.disease; | 125 |
| abstract_inverted_index.findings | 207 |
| abstract_inverted_index.hospital | 139 |
| abstract_inverted_index.immunity | 146 |
| abstract_inverted_index.patients | 9, 15, 95, 126, 179 |
| abstract_inverted_index.people's | 198 |
| abstract_inverted_index.practice | 228 |
| abstract_inverted_index.required | 191 |
| abstract_inverted_index.revealed | 149 |
| abstract_inverted_index.sequelae | 233 |
| abstract_inverted_index.severity | 114, 131 |
| abstract_inverted_index.symptoms | 79, 111 |
| abstract_inverted_index.tailored | 172 |
| abstract_inverted_index.Moreover, | 144 |
| abstract_inverted_index.attention | 183 |
| abstract_inverted_index.comparing | 4 |
| abstract_inverted_index.condition | 20 |
| abstract_inverted_index.confirmed | 33 |
| abstract_inverted_index.depending | 157 |
| abstract_inverted_index.developed | 18 |
| abstract_inverted_index.different | 145 |
| abstract_inverted_index.emphasise | 166 |
| abstract_inverted_index.evaluated | 40 |
| abstract_inverted_index.fine-tune | 193 |
| abstract_inverted_index.following | 36 |
| abstract_inverted_index.including | 25 |
| abstract_inverted_index.infection | 12 |
| abstract_inverted_index.initially | 132 |
| abstract_inverted_index.long-term | 100 |
| abstract_inverted_index.outcomes. | 143 |
| abstract_inverted_index.pathogen. | 187 |
| abstract_inverted_index.pathogens | 201 |
| abstract_inverted_index.prognosis | 83, 122, 156 |
| abstract_inverted_index.regarding | 229 |
| abstract_inverted_index.scholarly | 210 |
| abstract_inverted_index.underlain | 153 |
| abstract_inverted_index.SARS-CoV-2 | 11 |
| abstract_inverted_index.components | 118 |
| abstract_inverted_index.considered | 74 |
| abstract_inverted_index.dissimilar | 155 |
| abstract_inverted_index.emphasizes | 108 |
| abstract_inverted_index.experience | 134 |
| abstract_inverted_index.favourable | 82 |
| abstract_inverted_index.infection. | 162 |
| abstract_inverted_index.infections | 24 |
| abstract_inverted_index.infectious | 186 |
| abstract_inverted_index.management | 176 |
| abstract_inverted_index.pathogens, | 148 |
| abstract_inverted_index.suggesting | 52 |
| abstract_inverted_index.vaccinated | 55 |
| abstract_inverted_index.well-being | 199 |
| abstract_inverted_index.comorbidity | 101 |
| abstract_inverted_index.development | 69 |
| abstract_inverted_index.expressive. | 104 |
| abstract_inverted_index.infections. | 65 |
| abstract_inverted_index.respiratory | 50 |
| abstract_inverted_index.substantial | 49 |
| abstract_inverted_index.vaccination | 38 |
| abstract_inverted_index.application, | 88 |
| abstract_inverted_index.demonstrated | 96 |
| abstract_inverted_index.establishing | 120 |
| abstract_inverted_index.improvement, | 98 |
| abstract_inverted_index.involvement, | 51 |
| abstract_inverted_index.neurological | 232 |
| abstract_inverted_index.Campylobacter | 26 |
| abstract_inverted_index.statistically | 141 |
| abstract_inverted_index.understanding | 216 |
| abstract_inverted_index.manifestations | 220 |
| abstract_inverted_index.plasmapheresis | 87 |
| abstract_inverted_index.characteristics | 222 |
| abstract_inverted_index.hospitalisation | 47 |
| abstract_inverted_index.post-infectious | 231 |
| abstract_inverted_index.COVID-19-associated | 93 |
| abstract_inverted_index.Campylobacter-associated | 71 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 4 |
| citation_normalized_percentile.value | 0.06111962 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |